Sep 17, 2020 | Uncategorized
nnOne of the biggest changes to our ICD-10-CM books for the upcoming new year will be the addition of Chapter 22: Codes for special Purposes (U00-U85). Although this new chapter only consists of two codes and these codes were actually created and valid as early as April 2020, the creation of this chapter is proof that lessons from our current pandemic have been learned. Read below for more!nnHere are the codes, and their guidelines as printed in the Official ICD-10-CM FY 2021 Guidelines;nn
Sep 10, 2020 | Uncategorized
As 2021 approaches and new E/M changes are being implemented, it’s time to prepare your practice and sign up for training. Contact Welter Healthcare Partners and sign up today to have these new policies under your belt before 2021.nn Ginger Avery, CPC, CPMA, CRC, is the Coding and Compliance Manager at Welter Healthcare Partners, Inc. Below, she is providing fourteen operational extremities on how to plan ahead in order to be ready for these administrative changes!nnThe 2021 E/M code changes are set to deliver a powerful mix of updates to help streamline documentation practices and reduce administrative burden. Medical practices are encouraged to start planning now for operational and administrative workflow adjustments that will be a result of this momentous occasion.nn1. Identify/Assign Project Lead. This transition will affect everyone in the organization including coders, billers, other non-clinical staff, clinical staff, and clinicians. A designated project lead will help assure your clinic is prepared to streamline processes before the changes take effect on January 1, 2021.nn2. Make Time for Meetings. Schedule time for meetings to review the changes and address questions. Track goals and milestones during the transition process. Organizations are encouraged to recognize the significance of this event and prioritize time to prepare for changes.nn3. Make a List of Necessary Changes. Forms, templates, and contracts need updated, electronic health records and practice management systems need upgraded, several experts will be noted.nn4. Update Policies, Procedures, Practice Protocols & Compliance Plan. Policies, Procedures, Protocols should all be in alignment with the new guidelines.nn5. Review Medical Malpractice Liability. Although the “counted” documentation requirements have lessened with the updates, clinicians are reminded to tell clear stories, documenting the clinically relevant details of each encounter. The new guidelines state that office visits include “a medically appropriate history and/or physical examination when performed.” Regardless of the changes, it is important to remember that the burden of proof lies within the documented details. Supportive documentation will help guard against fraud & abuse law infractions.nn6. Assess Financial Impact. Guard against an unanticipated financial impact by understanding the rules in advance and performing a prospective payment analysis. Be prepared to adjust business practices depending on practice needs.nn7. Check with EHR vendors. Check with EHR vendors to assure their systems are updated appropriately prior to Jan 1st.nn8. Consider Coding Support. Establish strong coding/auditing resources and expertise early in the planning process.nn9. Conduct Current Coding/Documentation Assessment. Review current documentation practices and system functionality to address specific areas of interest for education development. This small audit sample should be conducted by an outside auditing source to provide an unbiased evaluation with appropriate recommendations.nn10. Provide Education. Educate clinicians appropriately about documentation that impacts medical decision making and how to become proficient with recognizing complexity in alignment with the new guidelines. The new guidelines provide definitions and descriptions that clarify many details that were previously left subject to interpretation. For example, an Undiagnosed new problem with uncertain prognosis is defined in the 2021 guidelines as, “A problem in the differential diagnosis that represents a condition likely to result in a high risk of morbidity without treatment. An example may be a lump in the breast.”nn11. Conduct a Time Study. Have clinicians track the total time related to each patient encounter for the day to determine whether current processes are set to capture total encounter time appropriately.nn12. Understand Employer and Payor Requirements. Employers or payors may still require documentation of additional information above and beyond the new E/M office visit coding guidelines. Careful evaluation of the flexibilities allowed under the new guidelines will ensure that the documentation satisfies any other obligations and requirements that they may be expected to fulfill within their contracts.nn13. Consider How the New E/M Guidelines Impact Your Specialty. For example, pain management practices will use the new E/M guidelines for office visits, but they’ll need to stick to the current guidelines for codes such as subsequent hospital visit code 99232 and subsequent nursing facility code 99308, which were among the top 10 E/M visit codes for the specialty according to the latest Medicare Part B utilization data.nn14. Download and study the materials the AMA has published. The guidance includes a new medical decision making (MDM) table, new coding guidelines for office visits and prolonged service codes and a detailed list of relevant definitions.nnResourcesnnImplementing CPT® Evaluation and Management (E/M) revisionsnnTable 2 – CPT E/M Office Revisions Level of Medical Decision Making (MDM)nn10 tips to prepare your practice for E/M office visit changes
Sep 10, 2020 | Uncategorized
The report below describes a patient undergoing a transcatheter aortic valve replacement. The entire procedure has been documented in detail, describing the step by step process used by doctors to carry out the surgery. Keep reading for more on how this procedure was performed.nnDo you have a complicated surgery case that needs help with coding? Welter Healthcare Partners would love to help! Please upload the operative note by clicking on the link below. Remember to remove ALL patient protected health information and organization identifiers. Welter Healthcare Partners will not use any medical records submitted in which PHI is not removed and protected. nn– Click Here to Submit Redacted Surgery Case Study –nnDate of Procedure: XX/XX/20nnReferring Physician: A.M., MDnnPerforming Physicians: L. V., MD and S. P., DO. Both co-surgeons participated jointly in this catheter-based procedure.nnAssisting Physician: S. L., MD. A second interventional cardiologist was required for this procedure due to complex anatomic factors resulting in the need for a second operator with complex catheter training.nnAnesthesiologist: A. T., MD and R.S., MDn
Pre-Procedure Diagnoses:
n
n
- Severe, symptomatic aortic valve stenosis
n
n
Post-Procedure Diagnoses:
n
n
- Successful transcatheter aortic valve replacement 23 mm Sapien Ultra
n
- No significant paravalvular regurgitation.
n
- Transvalvular mean gradient was reduced from 57 mmHg to 3 mmHg
n
- Aortic valve pathology: Tricuspid
n
n
Procedures Performed:
n
n
- Transfemoral transcatheter aortic valve replacement
n
- Balloon aortic valvuloplasty using an 18 mm Z-med balloon
n
- Ultrasound guidance for arterial and venous access.
n
- Aortography
n
- Perclose Proglide deployment
n
nIndications 89 year old female with a history of severe, symptomatic aortic stenosis. The patient was evaluated by a multidisciplinary team and deemed an appropriate candidate for TAVR.n
Description of Procedures:
nThe patient was brought to the hybrid operating room in the fasting and non-sedated state. The patient underwent monitored anesthesia care and was prepped in the usual sterile fashion. Transthoracic echocardiography was obtained for baseline assessment. Using ultrasound guidance and a micropuncture needle, the left femoral artery and left femoral vein were punctured and a 6 Fr sheath and 6 Fr sheath were, respectively, placed using the Seldinger technique. The right femoral artery was punctured and pre-close with Perclose devices was performed. Unfractionated heparin (UFH) was administered to achieve a goal activated clot time (ACT) > 250 sec. A 14 Fr E-Sheath was placed without difficulty.nnA transvenous pacemaker was placed in the right ventricle and threshold testing was performed. A pigtail catheter was advanced into the aortic root and aortography was performed to confirm co-planar angles. The aortic valve was crossed with a AL1 catheter and simultaneous aortic and ventricular pressures were obtained. Next, a Safari wire was placed in the left ventricle. After aortography was performed, an 18-mm Z-med balloon was delivered. After rapid pacing started, balloon aortic valvuloplasty was performed using the Z-med balloon, which was inflated at nominal pressure, and deflated. This was removed via the sheath.nnA 23 mm Sapien Ultra Valve was prepped according to manufacturer’s recommendations. The delivery system was introduced into the descending aorta and the valve was mounted onto the balloon in the usual fashion. The Sapien valve was then advanced across the stenotic aortic valve and carefully positioned during aortography. The valve was deployed during rapid pacing at 180 bpm. The delivery system was removed and transthoracic echocardiography revealed no significant paravalvular leak and a mean gradient of 3 mmHg.nnThe pacemaker was removed and iliofemoral aortography revealed absence of vascular complications (e.g. dissection, perforation). The E-sheath was removed and hemostasis was achieved with application of the Perclose Proglide devices. The contralateral arterial sheath was removed and hemostasis was achieved with application of a Perclose Proglide device. The venous sheath was removed and hemostasis was achieved with application of a Perclose Proglide device.n
Hemodynamics:
nBaseline aortic valve gradient: Mean 57 mmHg Final aortic valve gradient: Mean 3 mmHgnnEchocardiography: Refer to the separate TTE note for full details of the findings. Briefly, there is severe aortic stenosis at baseline. Following implant of a 23 mm Sapien Ultra valve, the gradient improved from 57 mmHg (from previous echo) to 3 mmHg. There is no significant paravalvular regurgitation. No new pericardial effusion at the conclusion of the procedure.nnEstimated Blood Loss: < 50 cc nnComplications: None apparent nnImplantations: 23 mm Sapien Ultra Valve nnContrast: 100 ccn
Summary:
nThe patient underwent successful balloon aortic valvuloplasty and transfemoral transcatheter aortic valve replacement for severe, symptomatic aortic stenosis using a 23 mm Sapien Ultra valve. The procedure was without apparent complication.n
Recommendations:
n
n
- Transfer to the ICU in stable condition.
n
- Bedrest for 6 hours.
n
- Aspirin 81 mg daily starting tomorrow morning.
n
- Restart Eliquis 5 mg po BID in 6 hours if no bleeding issues.
n
- Transthoracic echocardiogram to be performed tomorrow to re-evaluate valvular hemodynamics
n
Sep 3, 2020 | Uncategorized
Please find the latest updates from the major commercial health insurance payers in Colorado with more information on how they will be handling COVID-19 moving forward. As you very well know, the health plans have been changing their policies and procedures in response to COVID-19 as the Public Health Emergency (PHE) continues to unfold. These rolling changes will impact benefits for members and will also influence some of the services you may provide.
n
This update has information from each health plan to keep you informed on any updated timelines, member cost-sharing responsibility, and covered services for the remainder of the PHE. As you can see, most of the dates for telehealth services have been pushed back to allow continued services for members at home.
n
Your team at WHP will continue to monitor the coming changes to keep you up to date any new timelines or rule updates. Based on the current track record, we suspect this will all change again. Click here to download and print the PDF.
n nnnn
Sep 3, 2020 | Uncategorized
It is not breaking news that COVID-19 is affecting every aspect of society and our overall health. In an August 14, 2020 release from the American Medical Association (AMA), the under-reported issue of opioid-related overdoses is discussed. Read below to find out more.nnAccording to this brief, “More than 40 states have reported increases in opioid-related mortality as well as ongoing concerns for those with a mental illness or substance use disorder in counties and other areas within the state”. Included in this brief are links for individual state reports regarding substance abuse and the AMA’s request for action by governors and state legislatures.nnWhen managing patients with chronic pain who have been prescribed opioid treatments there are certain requirements these patients must adhere to in order to remain on opioid treatment. These requirements, like almost every other aspect of our lives has been interrupted. What is your practice and clinical staff doing to stay compliant with opioid prescriptions?nnClick here to read more from the American Medical Association
Aug 27, 2020 | Uncategorized
Laws regarding physician self-referral and anti-kickback have been delayed due to the need for revisions. This delay has prevented physicians from being able to implement new solutions without the concern that they could be in violation of the law. Read the article below to learn more.nnThe much-anticipated final rule updating physician self-referral and anti-kickback laws has been pushed back for one year, the Department of Health and Human Services announced this week.nn”We are still working through the complexity of the issues raised by comments received on the proposed rule,” HHS Deputy Executive Secretary Wilma M. Robinson wrote in a public notice, “and therefore we are not able to meet the announced publication target date.”nnInstead, she said, the timeline has been pushed back to August 31, 2021.nnThe news was a disappointment for the American Hospital Association, which earlier this month had urged the Office of Management and Budget for an “expeditious review and release of the Physician Self-Referral and Anti-Kickback Statute final regulations” that the Centers For Medicare & Medicaid Services had submitted in July.nnThe AHA has long complained that the Stark Law prohibiting physician self-referrals is a major hindrance in the transition to value-based care, and that the proposed reforms would “provide space for the types of innovative arrangements among hospitals and physicians that can enhance care coordination, improve quality and reduce costs.”nnThe proposal would create new and permanent exceptions to the 30-year-old Stark Law for value-based arrangements, permitting physicians and other providers to try innovating solutions without fear that their legitimate efforts to coordinate care might violate the law, according to an agency fact sheet.nnThose new exceptions would apply for Medicare and non-Medicare populations alike.nnAHA General Counsel Melinda Hatton on Wednesday “strongly urged CMS to move more quickly to finalize these improvements.”nn”This is an extremely disappointing setback for hospital and health system efforts to continue to innovate coordinated care arrangements, which have great potential to benefit patients, lower costs and make care more accessible for everyone,” she said.nnThe proposed rule was first unveiled in October 2019, as part of the Trump administration’s “Patients Over Paperwork” initiative.nn”We serve patients poorly when government regulations gather dust in the attic: they become ever more stale and liable to wreak havoc throughout the healthcare system,” CMS Administrator Seema Verma said at the time.nnOriginal article published on healthleadersmedia.com
